You are now leaving the Lilly Medical website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Basaglar ® (insulin glargine) injection
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Basaglar® (insulin glargine) be used in animals?
Eli Lilly and Company recommends that owners contact their veterinarian for information on the use of insulin in their pets.
Use of Insulin in Animals
Basaglar® (insulin glargine) 100 units/mL is not approved for use in animals.1 While insulins are available for use in animals, Eli Lilly and Company recommends that owners contact their veterinarian for information regarding the use of insulins in their pets.
Enclosed Prescribing Information
Reference
1Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Date of Last Review: May 27, 2024